Lesaffre Acquires a Majority Interest in Envera, an Innovative U.S. Bioscience-Based Company

As part of its ongoing expansion strategy in nutrition and health, Lesaffre, a global key player in the yeasts and fermentation industry today announces the acquisition of a majority interest in Envera.  

Founded in 2004 by Michael L. Matheny, a long-time microbiologist entrepreneur and executive, Envera is a full solution provider in the field of microbiology. Based in West Chester, Pennsylvania, with experienced researchers, Envera develops specific microbial-based products for a range of applications.

With this transaction, Lesaffre will enhance its presence and product offering in the fast-growing nutritional ingredients and health sector. In July 2017, Lesaffre announced an investment in Intralytix, another US biotechnology company and leader in bacteriophage technology.  

Antoine Baule, Lesaffre’s Chief Executive Officer says: “Lesaffre welcomes this acquisition which is entirely in line with its strategic development objectives. We are pleased to contribute to Envera’s development and to build upon the skills and expertise of the team in place. The specific technology and the strains collection developed by the company will provide a substantial addition to our current portfolio”.  

Paolo Rossi, President of Lesaffre’s Nutrition and Health activity, adds: “Envera’s impressive range of bacteria strains and products will enable us to widen our offering of microorganisms to our customers, especially in the field of human, animal and plant care activity. What’s unique about Envera is its experience in the isolation, selection, production and formulation of microbial cultures.”

Michael L. Matheny, President of Envera comments: “I am delighted to have partnered with Lesaffre, a French family owned company, known and recognized internationally for its expertise and professionalism in fermentation. I am confident the synergies between our companies, coupled with Lesaffre’s resources and connections around the world, will enable Envera to significantly accelerate its growth.”

About Lesaffre

As a key global player in yeasts and fermentation, Lesaffre designs, manufactures and markets innovative solutions for baking, food taste & pleasure, health care and biotechnology.  A family group founded in northern France in 1853 and now a multi-national and a multicultural company, Lesaffre is committed to working with confidence to better nourish and protect the planet.  In close collaboration with its clients and partners, Lesaffre employs 9,500 people in more than 70 subsidiaries, based in about 40 countries.  Lesaffre has global revenues of more than 1.9 billion euros, over 40% of which are in in emerging markets.

More information: www.lesaffre.com

About Envera

Envera is a bioscience-based company focused on the production of environmentally friendly products. Our 26 employees bring decades of experience in the isolation, large scale production, stabilization, and product formulation of microorganisms, making Envera a leader in the development and commercialization of microbial and enzyme based products for the consumer, institutional, agricultural, wastewater, and bioremediation markets. Envera’s technology platform includes expertise in the areas of bacteriology, mycology, enzymology, and chemistry.

More information: www.envera.com

Press contacts: